Experimental chemotherapy uses stealth tactic to activate inside cancer cells

UC Irvine researchers are developing an experimental chemotherapy approach designed to mitigate the damage healthy tissue typically suffers from potent cancer drugs. The team is implementing a safety lock on a highly effective medication, ensuring it remains inactive until it reaches its intended target. This mechanism is specifically engineered to respond to the internal environment of cancer cells that exhibit high levels of protein-destroying activity.

The proposed solution addresses the fundamental challenge of chemotherapy by allowing the drug to activate only after entering these specific cancer cells. By restricting the drug's potency to the tumor site, the method aims to preserve the integrity of surrounding healthy tissue. This stealth tactic represents a targeted strategy to enhance the safety profile of existing powerful cancer treatments.